A study to determine a capillary alternative to the gold standard oral glucose tolerance test - Protocol [version 1; peer review: 1 approved, 2 approved with reservations] by Gareth Dunseath, John A Todd, Colin Dayan, Steve Luzio, Rachel E J Besser, M. Loredana Marcovecchio, Rabbi Swaby, Tabitha Randell, Claire Scudder, Yuk-Fun Liu, Kathleen Gillespie

Get full text

Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol by Sandra Hummel, Alexandra Käßl, Stefanie Arnolds, Peter Achenbach, Reinhard Berner, Kristina Casteels, Heikki Hyöty, Olga Kordonouri, Helena Elding Larsson, Markus Lundgren, M. Loredana Marcovecchio, Catherine Owen, Markus Pfirrmann, Steve Robson, Agnieszka Szadkowska, Agnieszka Szypowska, Timothy Tree, Andreas Weiss, Anette-Gabriele Ziegler, Ezio Bonifacio

Get full text

Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data by Farid H. Mahmud, Antoine B. M. Clarke, Yesmino Elia, Jacqueline Curtis, Paul Benitez-Aguirre, Fergus J. Cameron, Scott T. Chiesa, Cheril Clarson, Jennifer J. Couper, Maria E. Craig, R. Neil Dalton, Denis Daneman, Elizabeth A. Davis, John E. Deanfield, Kim C. Donaghue, Timothy W. Jones, Sally M. Marshall, Andrew Neil, M. Loredana Marcovecchio

Get full text

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagn... by Simon Bond, David Dunger, Mark Wilson, Adrian Mander, Mikael Knip, Anita Chhabra, M Loredana Marcovecchio, Charlotte S Wilhelm-Benartzi, Michael J Haller, Timothy Tree, Hilde Morobé, Sarah E Miller, Sylvaine Bruggraber, Diane Picton, Katrina Gatley, A Emile J Hendriks, Bärbel Aschemeier-Fuchs, Lut Overbergh, Jaivier Pall, Olivier Arnaud, Almut Nitsche, Anke M Schulte

Get full text